Expression of PHGPx in mammalian cells and its antiviral effect against coxsackievirus group

To express human phospholipid hydroperoxide glutathione peroxidase (PHGPx) in eukaryotic cells and to study its antiviral effect against Coxsackievirus B3m (CVB3m) in vitro， PHGPx cDNA was amplified from a human testis library using specific primers and cloned into expression vector pcDNA3.1His. Expression of PHGPx was performed in COS-1 cells. The antiviral effect was studied by the treatment of HeLa cells with the recombinant PHGPx. Results showed that the activity of PHGPx expressed in COS-1 cells was 5-fold higher than that in control group, and it inhibited the cytopathic effect on HeLa cells caused by CVB3m. It can be concluded that recombinant PHGPx expressed in COS-1 cells has antiviral effect against CVB3m in vitro.     

结核杆菌Ag85B的表达纯化

为构建抗结核病新型疫苗,以结核杆菌标准毒力株H37Rv DNA为模板,用PCR法克隆抗原85B的编码基因,将该基因重组到表达型质粒pQE30中,表达的His6 Tag-Ag85B融合蛋白分子质量约32ku,用亲和层析一步法纯化的重组蛋白纯度好,得率高,为进一步的免疫研究创造了条件。     

Controlled expression of enhanced green fluorescent protein and hepatitis B virus precore protein in mammalian cells

A novel tetracycline regulation expression system was used to regulate the expression of enhanced green fluorescent protein (EGFP) and hepatitis B virus precore protein in the mammalian cell lines with lipofectAMINE. Flow cytometry assays showed that application of the system resulted in about 18-fold induction of EGFP expression in CHO cell lines and 5-fold induction in SSMC-7721 cells and about 2-fold in the HEK293 cells. Furthermore, the effective use of this system for the controlled expression of HBV precore protein gene in hepatocellular carcinoma cells was tested.     

HBV基因型与干扰素及核苷类似物抗病毒治疗疗效的关系

目的:介绍乙型肝炎病毒(HBV)基因型与抗病毒治疗疗效关系的最新进展.方法:综合分析近年国内外有关HBV基因型与抗病毒治疗疗效关系的文献资料.结果:感染HBV基因型A的慢性乙型肝炎患者对干扰素治疗的应答率高于基因型D,基因型B高于基因型C;HBV基因型与核苷类似物治疗疗效的关系目前尚存争议;基因型E、F、G、H是否影响抗病毒疗效报道较少.结论:HBV基因型与抗病毒治疗疗效存在一定的相关性;HBV基因型的研究将有助于临床抗病毒治疗方案的优化.     

Secretory expression of the fusion protein composed of human IL-2 and PreS antigen of hepatitis B virus in mammalian cells

In order to make entire HBV pmSAg secrete from mammalian cells, we conatmcted an eukaryotic expression vector by using leader sequence of human interleukin-2 (IL-2) as secretory signal peptide, and using high hydmphilic amino acids as the linker between IL-2 C end and preSAg N end. As a result, the IL-2preS fusing protein could be secreted from mamalian cells transfected with the reconstructed vector and the expression efficiency was identical to that of natural IL-2. It was considered that the retentive effect of preSlAg could be successfully bypassed. The results not only laid a theoretical and practical foundation for constructing specific gene vaccine against HBV persistent infection, but also supplied experimental evidence for studying modulation of protein secretory expression.     

靶向基因疫苗pcDNA3/MDC-VP1的构建及免疫效果

用RT-PCR扩增小鼠巨噬细胞源趋化因子(macrophage-derived chemokine,MDC)基因,与柯萨奇病毒B组3型(CVB3)VP1基因通过一个编码10个氨基酸残基的接头序列(Gly4Ser)2相连,形成融合基因MDC-VP1,构建真核表达质粒pcDNA3/MDC-VP1,作为疫苗免疫BALB/c小鼠.3次免疫后,pcDNA3/MDC-VP1组小鼠血清中和抗体滴度明显高于pcDNA3/VP1组;而病毒滴度低于pcDNA3/VP1组.用10 LD50CVB3攻击,pcDNA3/MDC-VP1组小鼠生存率为50%,用Kaplan-Meier法进行生存分析,生存率高于其他各组.     

棉铃虫组织蛋白酶B在杆状病毒表达系统中的表达及鉴定

以棉铃虫（Helicoverpa armigera）组织蛋白酶B作外源基因重组构建克隆载体,自重组菌株HCB-DH10Bac、Histag-HCB-DH10Bac中提取穿梭质粒,脂质体法转染草地贪夜蛾卵巢细胞系Sf21细胞,转染液再感染细胞,收集感染3～4d的上清液,提取芽生病毒的DNA,PCR法鉴定外源HCB基因,感染上清进行SDS-PAGE、Western-blotting、蛋白酶活性检测．结果：感染上清中的芽生病毒的DNA作模板扩增出预期的1700bp片段,SDS-PAGE、westem-blotcing检测均在28ku处有明显表达产物,且表达产物有蛋白水解活性．     

B淋巴细胞刺激因子基因的克隆及在大肠杆菌中的高效表达

聚合酶链式反应(PCR)扩增获得了编码BLys(134—285AA)的cDNA片段,该片段以限制性内切酶BglⅡ和HindⅢ双酶切插入pET32a载体。测序表明除(ATA^263→ATG^263)突变并导致了氨基酸(1263M)突变外,其余序列与Genbank报道的序列一致。蛋白表达用异丙基-β-硫代半乳糖苷(IPTG)诱导,SDS—PAGE表明：在33ku处有明显的融合蛋白表达,其表达水平高达总茵体蛋白的50％。点印迹证实融合蛋白能与anti—His6Tag抗体反应。生物学活性研究表明BLys协同丝裂霉素能明显地抑制HeLa细胞的生长。     

天蚕抗菌肽B在毕赤酵母中的表达

Cecropins B是一种昆虫抗菌肽,具有分子量小,热稳定性、水溶性好、抗菌谱广等优点,更为重要的是抗菌肽对真核细胞几乎没有作用,仅仅作用于原核细胞和发生病变的真核细胞,是目前已知天然抗菌肽中活力最强的一种。根据毕赤氏巴斯德酵母(Pichia pastoris)偏好密码子,改造并化学合成天蚕素基因B,克隆到pPIC9K载体中,构建分泌型重组酵母表达载体CB-pPIC9K,转化Pichia pastoris受体菌KM71,在醇氧化酶(AOX)启动子调控下,Cecropin B获得表达,分子量约3.8KD,摇瓶发酵产率可达到200μg/mL,并对其抗菌活性进行了初步测定。结果表明我们表达的重组Cecropins B对G-菌有较好的抑菌活性,且具有较好的热稳定性。这些特点使得重组抗菌肽Cecropins B在食品防腐、疾病防治和动物饲料添加剂等方面显露出很好的应用前景。     

人白血病抑制因子真核表达载体的构建及在哺乳动物细胞中的表达

应用RT-PCR方法从人子宫内膜组织总RNA扩增出hLIF的全长基因,然后将其克隆至pcDNA3上,成功构建了重组真核表达载体pcDNA3/hLIF.利用脂质体介导将这一表达载体导入COS-7细胞和CHO-K1细胞,分别获得了hLIF的瞬时表达和稳定表达,为进一步进行hLIF生物学功能研究和hLIF在哺乳动物细胞中的高表达研究奠定了基础.     

HCV非结构区NS3-5B蛋白的真核表达载体构建及其在BHK-21细胞中的表达

通过PCR方法扩增出HCV NS3-5b全长基因序列,克隆入真核表达载体pIRES2-EGFP中,构建重组质粒pIRES2-EGFP-NS3-5b。利用脂质体将该质粒转染至BHK-21细胞,通过荧光成像和Western Blot检测NS3-5b基因的表达。结果显示成功构建了真核表达质粒pIRES2-EGFP-NS3-5b,并且NS3/4A蛋白和NS5B蛋白得到特异性表达,为下一步建立HCV RdRp活性的细胞评价系统和动物模型评价系统奠定了实验和理论基础。     

小鼠IL-6基因的克隆及表达载体的构建

采用常规的分子生物学技术,从小鼠骨髓细胞中克隆了含信号肽序列的IL－6,并构建了表达载体,序列分析表明所克隆的IL－6序列与献已报道的一致,构建的表达载体经鉴定正确。     

粘膜佐剂霍乱毒素B亚单位的克隆与表达

目的 :构建表达粘膜佐剂霍乱毒素B亚单位 (CTB)基因的重组质粒 ,并在大肠杆菌中表达获得基因重组蛋白。方法 :用PCR方法从霍乱弧菌中扩增CTB片段 ,将其转入原核载体质粒pET-32a( ) ,在大肠杆菌Top10克隆 ,并在BL21中表达。结果 :重组质粒PET-CTB的全长序列经分析与基因文库公布的一致 ;表达蛋白经SDS-PAGE分析 ,相对分子量与文献相符 ;重组蛋白竟Westernblot检测有抗原性。结论 :基因重组菌表达的CTB蛋白可能作为有效、安全的粘膜佐剂用于口服疫苗的研制     

Expression of human clotting factor Ⅸ mediated by recom- binant lentiviral vector in cultured cells and hemophilia B mice

To explore the expression of human clotting factor Ⅸ (hFⅨ) cDNA in vitro and the feasibility of gene therapy for hemophilia B mice mediated by recombinant lentiviral vector, a recombinant hFⅨ lentiviral vector driven by ubiquitin-C promoter, FUXW, and by ABP liver specific promoter, FAXW, was constructed respectively. Recombinant lentivirus was harvested from 293T cells by calcium phosphate-mediated transient cotransfection of three plasmids (transgene vector, CMV腞8.2, VSV-G). hFⅨ expression was detected in supernatant of 293T, BHK and L-02 cells infected with FUXW virus, whereas higher expression of hFⅨ levels (630 ng/106 cells/48 h) was detected only in L-02 cells infected with FAXW virus. Serum hFⅨ antigen was detected in all hemophilia B mice treated with FAXW virus by tail vein injection, an efficiency level of hFⅨ was observed (45 ng/mL, approximately 1% of normal human levels), the expression lasted for more than 60 d. The results indicated that HIV-based lentiviral vectors offer a promising approach to the gene therapy of hemophilia B.     

乙型肝炎病毒HBX基因的克隆、表达和蛋白的纯化

克隆乙肝病毒X基因,并在大肠杆菌中进行表达和纯化。用PCR方法从结乙肝病毒基因组扩增出HBX基因片段,克隆至pMD18-T载体中。序列测定正确后,将其亚克隆到表达载体pProExHTa并在大肠杆菌BL21中表达。表达蛋白经SDS-PAG及Western-blot分析后,亲和层析法纯化蛋白。结果成功克隆了HBX基因,并对其在E.coli中进行了表达。SDS-PAGE及Western blot分析表明表达产物正确。通过IMAC纯化系统获得17 kD纯化蛋白,与文献报道相符。结果成功获得了纯化的HBX蛋白,为进一步研究HBX蛋白与宿主蛋白之间的相互作用奠定基础。     

纹皮蝇Hypodermin B基因在大肠杆菌中的表达

从纹皮蝇Ⅰ期幼虫中提取总RNA,RT-PCR扩增纹皮蝇Hypodermin B(HB)基因.将扩增基因进行克隆测序,构建原核表达载体pET30-HB,转化大肠杆菌BL21(DE3).用IPTG诱导表达后,得到表达量达全菌蛋白30%以上的特异性蛋白.SDS-PAGE分析表明表达产物主要以包涵体形式存在.Western blotting检测结果表明,获得的重组蛋白为重组Hypodermin B,具有较好的反应原性.     

人源蛋白酪氨酸磷酸酶PTP1B功能域及其全酶的原核表达及活性比较

通过设计引物,利用RT-PCR从人肝癌细胞(huh-7)中克隆蛋白酪氨酸磷酸酶(PTP1B)全长及功能域PTPc的cDNA序列并连接到pGEM-T Vector载体上,测序正确的cDNA序列连接到表达载体pET-32a(+)上,分别在大肠杆菌Transetta(DE3)和BL21(DE3)菌株中稳定表达目标蛋白,经Ni 2+亲和柱纯化后目的蛋白达到了电泳纯,通过酶促动力学方法分析两种蛋白的体外活性.本实验成功表达了PTP1B和PTPc可溶性蛋白,并发现Transetta(DE3)菌株较BL21(DE3)有更高的蛋白表达能力;酶促动力学分析表明,PTP1B全酶的Vmax为16.13mmol·L-1·s-1,Km为0.94mmol/L;其功能域PTPc的Vmax为5.49mmol·L-1·s-1,Km为0.54mmol/L.表明PTP1B全酶的活性高于PTPc功能域的活性.     

RNA interference-mediated inhibition of Hepatitis B Virus replication

Persistent and recurrent infection of hepatitis B virus (HBV) represents one of the most common and severe viral infections of humans, and has caused a formidable health problem in the affected countries. Currently used antiviral drugs have a very limited success on controlling HBV replication and infection. RNA interference (RNAi), a process by which double-stranded RNA (dsRNA) directs sequence-specific degradation of target mRNA in mammalian and plant cells, has recently been used to knockdown gene expression in various species. In this study, we sought to determine whether RNAi-mediated silencing of HBV viral gene expression could lead to the effective inhibition of HBV replication. We first developed RNAi vectors that expressed small interfering RNA (siRNA) and targeted the HBV core or surface gene sequence. Our results demonstrated that these specific siRNAs efficiently reduced the levels of corresponding viral RNAs and proteins, and thus suppressed viral replication. Treatment with siRNA gave the greatest reduction in the levels of HBsAg (92%) and in HBeAg (85%) respectively in the cultured cell medium. Our findings further demonstrated that the RNAi-mediated antiviral effect was sequence-specific and dose-dependent. Therefore, our findings strongly suggest that RNAi-mediated silencing of HBV viral genes could effectively inhibit the replication of HBV, hence RNAi-based strategy should be further explored as a more efficacious antiviral therapy of HBV infection.     

bcl-2基因及其蛋白在女性生殖系统疾病中的表达(综述)

bcl-2基因是细胞凋亡的抑制基因,该基因及其蛋白的异常表达与女性生殖系统疾病关系密切,可作为判断疾病预后的因素之一。